Gene Expression Say Goodbye to Verity: No Luck With Michigan VC Funds | GenomeWeb

Verity Biosystems was a promising little tech firm when it set up shop out of Wayne State University in Michigan (originally under the moniker Streamline Proteomics) in late 2001. Based on a multiplexed bead technology to study gene and protein expression, Verity investors were so excited that they got founder David O’Hagan to sign on the dotted line, promising to raise $2 million within four months.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.